Abstract
The aim of the present work was to prepare, characterize and evaluate the solubility and dissolution behavior of ketoprofen co-crystals. Fusion method was employed for the preparation of ketoprofen co-crystals. The co-formers selected were cinnamic acid, glutaric acid, maleic acid, malonic acid, nicotinamide, oxalic acid, p-amino-benzoic acid, pamino salicylic acid, saccharin and urea. The prepared ketoprofen co-crystals were characterized by FT-IR, DSC and XRD. Ketoprofen co-crystals were evaluated for solubility and dissolution. Micromeritic properties were evaluated for cocrystal exhibiting higher solubility. A Shift in the IR peaks was observed for all the prepared co-crystals with no presence of additional peaks. DSC studies showed decrease in the heat of fusion from 257.74 to 50.39 J/g and melting point of drug from 95.80 to 73.57°C in the co-crystals. XRD peaks exhibited different peak patterns than peaks shown by the pure ketoprofen. All the preparations exhibited enhanced aqueous solubility as well as dissolution when compared with pure ketoprofen. Amongst the co-crystals prepared, Ketoprofen-p-Amino-salicylic acid co-crystals, exhibited 14 fold increases in aqueous solubility and in vitro release was found to be 93.41% in 60 mins. This work demonstrates the potential of cocrystallization by fusion as screening method for particle engineering. The results demonstrate the feasibility of pharmaceutical co-crystal design for ketoprofen.
Keywords: Co-crystals, Co-formers, Fusion technique, Ketoprofen, Solubility.
Current Drug Therapy
Title:Enhancing Aqueous Solubility of Ketoprofen by Fusion Technique Using Suitable Co-formers
Volume: 9 Issue: 3
Author(s): Rudra Vaghela, Parthasarathi. K. Kulkarni, Umme Hani, Vegasna Naga Sravan Kumar Varma and Raizaday Abhay
Affiliation:
Keywords: Co-crystals, Co-formers, Fusion technique, Ketoprofen, Solubility.
Abstract: The aim of the present work was to prepare, characterize and evaluate the solubility and dissolution behavior of ketoprofen co-crystals. Fusion method was employed for the preparation of ketoprofen co-crystals. The co-formers selected were cinnamic acid, glutaric acid, maleic acid, malonic acid, nicotinamide, oxalic acid, p-amino-benzoic acid, pamino salicylic acid, saccharin and urea. The prepared ketoprofen co-crystals were characterized by FT-IR, DSC and XRD. Ketoprofen co-crystals were evaluated for solubility and dissolution. Micromeritic properties were evaluated for cocrystal exhibiting higher solubility. A Shift in the IR peaks was observed for all the prepared co-crystals with no presence of additional peaks. DSC studies showed decrease in the heat of fusion from 257.74 to 50.39 J/g and melting point of drug from 95.80 to 73.57°C in the co-crystals. XRD peaks exhibited different peak patterns than peaks shown by the pure ketoprofen. All the preparations exhibited enhanced aqueous solubility as well as dissolution when compared with pure ketoprofen. Amongst the co-crystals prepared, Ketoprofen-p-Amino-salicylic acid co-crystals, exhibited 14 fold increases in aqueous solubility and in vitro release was found to be 93.41% in 60 mins. This work demonstrates the potential of cocrystallization by fusion as screening method for particle engineering. The results demonstrate the feasibility of pharmaceutical co-crystal design for ketoprofen.
Export Options
About this article
Cite this article as:
Vaghela Rudra, Kulkarni K. Parthasarathi., Hani Umme, Varma Naga Sravan Kumar Vegasna and Abhay Raizaday, Enhancing Aqueous Solubility of Ketoprofen by Fusion Technique Using Suitable Co-formers, Current Drug Therapy 2014; 9 (3) . https://dx.doi.org/10.2174/1574885510666141209233056
DOI https://dx.doi.org/10.2174/1574885510666141209233056 |
Print ISSN 1574-8855 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3903 |
Call for Papers in Thematic Issues
Novel Therapeutic Approaches and Biomarkers for Chronic Kidney Disease (CKD)
The thematic issue on "Novel Therapeutic Approaches and Biomarkers for CKD" aims to provide a comprehensive exploration of cutting-edge strategies for the management of chronic kidney disease (CKD). This issue will delve into emerging therapeutic targets, focusing on critical aspects such as podocyte injury, endothelial dysfunction, and tubulointerstitial fibrosis, which ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Effects of Nicotine on the Cardiovascular System
Vascular Disease Prevention (Discontinued) Genetic Transmission of Cytochrome P450 2D6 (CYP2D6) Ultrarapid Metabolism: Implications for Breastfeeding Women taking Codeine
Current Drug Safety The Role of Sensing Peptides in the Cross-talk between Microbiota and Human Cancer Cells
Mini-Reviews in Medicinal Chemistry Ascorbic Acid: Its Role in Immune System and Chronic Inflammation Diseases
Mini-Reviews in Medicinal Chemistry Meet our Editorial Board Member
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Molecular Mechanisms Underlying the Dedifferentiation Process of Isolated Hepatocytes and Their Cultures
Current Drug Metabolism BPC 157 Rescued NSAID-cytotoxicity Via Stabilizing Intestinal Permeability and Enhancing Cytoprotection
Current Pharmaceutical Design Cardiovascular Pharmacogenomics
Current Pharmacogenomics and Personalized Medicine Green Factories for Biopharmaceuticals
Current Medicinal Chemistry <i>In Silico</i> and <i>In Vitro</i> Study: COX-2 Inhibition by Ethanol Extract of Dayak Onion Bulb (<i>Eleutherine Americana</i> Merr) as Treatment Innovation of Benign Prostatic Hyperplasia (BPH)
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Preclinical Drug Discovery in Colorectal Cancer: A Focus on Natural Compounds
Current Drug Targets Metformin: Repurposing Opportunities for Cognitive and Mood Dysfunction
CNS & Neurological Disorders - Drug Targets Functional Immunoregulation by Heme Oxygenase 1 in Juvenile Autoimmune Diseases
Current Gene Therapy Biofunctional Peptides from Milk Proteins: Mineral Binding and Cytomodulatory Effects
Current Pharmaceutical Design Aberrant DNA Methylation of SOCS1 Gene is Not Associated with Resistance to Imatinib Mesylate among Chronic Myeloid Leukemia Patients
Cardiovascular & Hematological Disorders-Drug Targets Pathogenesis, Experimental Models and Contemporary Pharmacotherapy of Irritable Bowel Syndrome: Story About the Brain-Gut Axis
Current Neuropharmacology Combining Angiogenesis Inhibitors with Radiation: Advances and Challenges in Cancer Treatment
Current Pharmaceutical Design Recent Applications of Chemiluminescence Assays in Clinical Immunology
Mini-Reviews in Medicinal Chemistry Targeting Vascular Redox Biology Through Antioxidant Gene Delivery: A Historical View and Current Perspectives
Recent Patents on Cardiovascular Drug Discovery Rational Design of CPP-based Drug Delivery Systems: Considerations from Pharmacokinetics
Current Pharmaceutical Biotechnology